PRESCRIPTION PATTERN IN COVID-19 PATIENTS ADMITTED TO A TERTIARY CARE CENTER IN KERALA
DOI:
https://doi.org/10.22159/ajpcr.2023v16i9.47984Keywords:
Prescription pattern,, COVID-19,, Antivirals in COVID-19, Anticoagulants.Abstract
Objectives: The objectives of the study were to analyze the prescribing pattern in COVID-19 patients and to identify the most commonly prescribed drugs and their routes.
Methods: A hospital-based retrospective observational study was conducted based on data of COVID-19 positive patients admitted over a period of 6 months, from May 1, 2020, to October 31, 2020. Relevant data were collected from medical records library.
Results: The prescriptions of 1223 COVID-19 positive patients were analyzed. Among them 63.7% were men (n=780). The mean age was 46.5 years. 49.9% (n=611) of our patients were mild cases, categorized as category A. 41.2% (n=505) were category B, and 8.7% came under the severe disease category C. Duration of hospital stay of the patients ranged from 1 to 44 days with a mean duration of 9 days. The most prescribed medication was paracetamol which was prescribed to 55% (n=679) of patients. From the 488 (39.9%) patients who received some antibiotic, the most frequently prescribed was azithromycin (80.1%) followed by ceftriaxone (17.2%) and cefotaxime (3.07%). 18.5% of patients were prescribed anticoagulants, the most common being LMWH-enoxaparin. 17.9% of patients received some systemic corticosteroids. Antivirals prescribed were favipiravir (7.4%), oseltamivir (4.7%), and 0.8% remdesivir.
Conclusion: Different drugs belonging to different groups have been prescribed, for symptomatic treatment of disease and its complications as a single effective drug has not been discovered. Almost all the drugs prescribed were generic drugs and were from the Essential List of Medicines-2015.
Downloads
References
Hui DS, Madani TA, Ntoumi F, Kock R, Dar O, Kock R, et al. The continuing 2019-nCoV epidemic threat of novel Coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91:264-6. doi: 10.1016/j.ijid.2020.01.009, PMID 31953166
Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel Coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One 2020;15:e0234765. doi: 10.1371/journal.pone.0234765, PMID 32574165, PMCID 7310678
Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA 2020;323:1499-500. doi: 10.1001/jama.2020.3633, PMID 32159735
World Health Organization. Statement on the Second Meeting of the International Health Regulations. Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV). Geneva: World Health Organization; 2005.
Covid-19 Body Count: India’s Low Mortality Rate and the Contrasting Pictures of Two States. News. Available from: https://www.news18. com/news/india/covid-19-body-count-indias-low-mortality-rate-and-the-contrasting-pictures-of-two-states-2578653.html [Retrieved on 2020 Apr 16], [Last accessed on 2023 Mar 20].
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020;20:533-4. doi: 10.1016/ S1473-3099(20)30120-1, PMID 32087114
World Health Organization. How to Investigate Drug use in Health Facilities: Selected Drug Use Indicators-EDM Research Series No. 007. Geneva: World Health Organization; 1993.
COVID-19 Treatment Guidelines-Kerala Dashboard. Available from: https://dhs.kerala.gov.in/wp-content/uploads/2020/08/covid-19-rx-guidelines-15th-august-2020.pdf [Last accessed on 2023 Mar 15].
World Health Organization. WHO COVID-19 Case Definition. Geneva: World Health Organization; 2020. Available from: https://www.mohfw.gov. in/pdf/revisednationalclinicalmanagementguidelineforcovid1931032020. pdf [Last accessed on 2023 Mar 15].
García-Posada M, Aruachan-Vesga S, Mestra D, Humánez K, Serrano-Coll H, Cabrales H, et al. Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean. J Infect Public Health 2021;14:696-701. doi: 10.1016/j. jiph.2021.02.013, PMID 34020208
Valladales-Restrepo LF, Giraldo-Correa JA, Aristizábal-Carmona BS, Constain-Mosquera CA, Sabogal-Ortiz A, Machado-Alba JE, et al. Prescription patterns of drugs given to hospitalized COVID-19 patients: A cross-sectional study in Colombia. Antibiotics (Basel) 2022;11:333. doi: 10.3390/antibiotics11030333, PMID 35326796
Murthy S, Archambault PM, Atique A, Carrier FM, Cheng MP, Codan C, et al. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: A national cohort study. CMAJ Open 2021;9:E181-8. doi: 10.9778/cmajo.20200250, PMID 33688026
Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: Clinical response to viral infection. J Biol Regul
Homeost Agents 2020;34:339-43. doi: 10.23812/editorial-conti-3, PMID 32253888
Gupta N, Agrawal S, Ish P, Mishra S, Gaind R, Usha G, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis 2020;90:193-6.
Patil SS, Pratap SN, Veer VT, Ullagaddi MB, Kangralkar VA, Patil AM. Evaluation of prescription pattern used in the treatment of COVID 19 patient’s. Int J Prog Res Sci Eng 2022;3:7-11.
Galani A, Alygizakis N, Aalizadeh R, Kastritis E, Dimopoulos MA, Thomaidis NS. Patterns of pharmaceuticals use during the first wave of COVID-19 pandemic in Athens, Greece as revealed by wastewater-based epidemiology. Sci Total Environ 2021;798:149014. doi: 10.1016/j.scitotenv.2021.149014, PMID 34325143
Singh S, Patil L, Nishat SA. A prospective cross-sectional study of prescription pattern of drugs used in the treatment of COVID-19 in a tertiary care hospital. Natl J Physiol Pharm Pharmacol 2022;12:1816- 20. doi: 10.5455/njppp.2022.12.03105202212032022
COVID-19 Interim Treatment Guidelines for Kerala State No./31/2020/Health; 2020. Available from: https://dhs.kerala.gov.in/ wp-content/uploads/2020/03/interim_24032020.pdf [Last accessed on 2023 Mar 20].
Chahin A, Dhabaan G, Buhaish A, Shorman M. Medications and supplements prescription patterns during COVID 19 pandemic in Yemen: A questionnaire-based study. Fortune J Health Sci 2022;5:522- 8. doi: 10.26502/fjhs.079, PMID 36644208
Ramakrishnan S, Nicolau DV Jr., Langford B, Mahdi M, Jeffers H, Mwasuku C, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): A phase 2, open-label, randomised controlled trial. Lancet Respir Med 2021;9:763-72. doi: 10.1016/S2213- 2600(21)00160-0, PMID 33844996
Recovery Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693-704. doi: 10.1056/ NEJMoa2021436, PMID 32678530
Chedid M, Waked R, Haddad E, Chetata N, Saliba G, Choucair J. Antibiotics in treatment of Covid-19 complications: Review of frequency, indications, and efficacy. J Infect Public Health 2021;14:570-6.
Molla MM, Yeasmin M, Islam MK, Sharif MM, Amin MR, Nafisa T, et al. Antibiotic prescribing patterns at COVID-19 dedicated wards in Bangladesh: Findings from a single center study. Infect Prev Pract 2021;3:100134. doi: 10.1016/j.infpip.2021.100134, PMID 34316576
Balasubramanian A, Khandelwal PN, Zaveri HT, Gandhi M, Ray I, Bhusare D. Drug utilization study in patients affected with COVID-19 in a dedicated COVID hospital. Natl J Physiol Pharm Pharmacol 2022;13:58-62. doi: 10.5455/njppp.2023.13.05243202226052022
Chindhalore CA, Dakhale GN, Gajbhiye SV, Gupta AV. Prescription pattern for antimicrobials and the potential predictors for antibiotics among patients with COVID-19: A retrospective observational study. J Clin Diagn Res 2022;16:FC15-9. doi: 10.7860/ JCDR/2022/56961.16874
Published
How to Cite
Issue
Section
Copyright (c) 2023 SUSAN JOSEPH, SAI NATHAN R
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
